Intracellular mechanisms promote tumor survival during hypoxia
Researchers at Northwestern University have identified how the P-TEFb protein complex helps tumor cells adapt to low-oxygen environments, known as hypoxia. This discovery explains how cancer cells survive and resist treatments like chemotherapy and immunotherapy.
Why it matters
Understanding these intracellular mechanisms provides a potential target for new cancer therapies that could prevent tumors from adapting to treatment, ultimately improving patient outcomes.
by Melissa Rohman, Northwestern University
The report is a straightforward summary of scientific research findings published in a peer-reviewed journal, maintaining a neutral and objective tone.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in